Search Type: drug or dietary supplement name
Search Term: metformin (FORTAMET, GLUCOPHAGE, GLUMETZA, RIOMET)


Drug Profiles | Worst Pills, Best Pills Newsletter Articles | Additional Information from Public Citizen

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a secondary subject of discussion

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Diabetes Drug Canagliflozin Doubles Risk of Amputations, FDA Warns [hide all summaries]
    (October 2017)
    Canagliflozin is one of three medications in the newest diabetes drug class. In this article, we discuss why the FDA recently required that a black-box warning about the risk of amputations be added to the product labeling of canagliflozin.
  • Incretin-Mimetic Drugs: Do Not Use to Treat Diabetes [hide all summaries]
    (August 2016)
    Incretin mimetics, one of the newer classes of diabetes drugs, are widely prescribed in the U.S. Find out why Public Citizen's Health Research Group recommends against using any of these medications.
  • Inhaled Insulin AFREZZA Ineffective, Can Damage Lungs [hide all summaries]
    (December 2015)
    Find out why this new form of insulin, which is inhaled as a powder, is a dangerous alternative to injected forms of insulin and never should have been approved by the Food and Drug Administration for the treatment of diabetes.
  • Risks but No Benefits to Taking Newest Drugs For Type 2 Diabetes [hide all summaries]
    (August 2015)
    The airwaves are filled with ads promoting the newest class of diabetes medications, often referred to as “flozins.” In this article, we review the serious safety concerns that have prompted us to designate all flozins as Do Not Use.
  • New Diabetes Drug Dapagliflozin (FARXIGA): Risks Outweigh Benefits [hide all summaries]
    (September 2014)
    Learn about the many dangers of one of the newest diabetes drugs approved in the U.S., dapagliflozin, which has been designated as Do Not Use by Public Citizen’s Health Research Group.
  • A Review of the ‘Gliptin’ Diabetes Drugs [hide all summaries]
    (March 2012)
    Find out why you should not use any of the three recently-approved diabetes drugs known as "gliptins".
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • Dangers of Mixing Alcohol with Certain Medications or Diseases [hide all summaries]
    (August 2008)
    The article discusses 273 drugs that can have harmful interactions with alcohol. Also reviewed are several ways in which these harmful interactions can occur: 1/ Medications Can Increase Alcohol Blood Levels 2/ Additive effects of medications and alcohol. One of the best- known drug-alcohol interactions is when alcohol, a depressant, is taken with other sedative medications, and excessive sedation or depression of respiration can occur 3/Alcohol can increase the blood levels of some medications leading to toxicity of these drugs. 4/ Alcohol also can reduce blood levels of some medications causing them to be less effective. Although some of the interactions between alcohol and medications mainly occur in people who drink heavily (three or more drinks on one occasion), many of these interactions may occur with much lower amounts of alcohol use, such as one to two drinks on an occasion. We strongly urge you to tell your physicians and other health care providers how much alcohol you are drinking so they can effectively assess the risks and advise you about the safe use of alcohol and medications.
  • FDA: Women Taking AVANDIA, ACTOS at Increased Risk of Fractures [hide all summaries]
    (July 2007)
    Yet another reason has arisen to support our several years-old warning not to use the diabetes drugs AVANDIA or ACTOS. Randomized trials of both drugs, compared to other diabetes drugs, showed an increase in fractures in women (not men) using them.
  • Sitagliptin (JANUVIA) for Type-2 Diabetes [hide all summaries]
    (June 2007)
    Worst Pills, Best Pills reviews side effects and long-term effects of type-2 diabetes drug sitagliptin (JANUVIA) in this article.
  • Adverse Drug Reactions Cause 1.4 Million Emergency Room Visits in 2004 and 2005 [hide all summaries]
    (January 2007)
    An estimated 701,547 patients were treated for adverse drug reactions in emergency rooms each year in 2004 and 2005, totaling 1.4 million visits to the emergency room. Of these, an estimated 117,318 patients were hospitalized each year. According to the study. 18 drugs were each, either independently or in combination with other drugs, implicated in one percent or more of the estimated adverse drug events. These drugs are listed in the table that accompanies this article along with the annual estimates of adverse drug events.

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion

SHOW primary search results for metformin (FORTAMET, GLUCOPHAGE, GLUMETZA, RIOMET)

Copyright © 2017 Public Citizen's Health Research Group. All rights reserved. https://www.worstpills.org/